Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia
Clinical trial NCT00590577 · COMPLETED
Trial details
- NCT number
- NCT00590577
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2008-03-01
- Enrollment
- 652
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.